secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUNIC, INC. (IMUX)
CIK:        0001280776
Form:       8-K
Filed at:   2026-01-06T23:59:59+00:00
Accession:  0001193805-26-000011
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunic transfers to Nasdaq Capital Market after bid price non-compliance; extended grace until June 22, 2026
--------------------------------------------------------------------------------

- Received approval on Jan 5, 2026 to transfer listing from Nasdaq Global Select to Capital Market, effective Jan 7, 2026.
- Failed to regain compliance with $1.00 minimum bid price rule by Dec 24, 2025 deadline.
- Transfer grants additional 180-day grace period until June 22, 2026 to meet bid price rule.
- Company notified Nasdaq it will seek reverse stock split if needed to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1280776/000119380526000011/0001193805-26-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1280776/000119380526000011/e665076_8k-immunic.htm
  HTML page:      https://secwatch.observer/filing/0001193805-26-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer